Karp Daniel 4

Accession 0001821825-25-000018

CIK 0001821825other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:44 PM ET

Size

27.9 KB

Accession

0001821825-25-000018

Form 4

Period: 2025-03-31

Executive VP, Corp. Dev.

Transactions

Exercise/Conversion
Common Stock
2025-03-31+4,294→ 44,515.46 total
Exercise/Conversion
Restricted Stock Units
2025-03-31−11,338→ 11,338 total
→ Common Stock (11,338 underlying)
Tax Payment
Common Stock
2025-03-31$14.51/sh−4,446$64,511→ 29,100.46 total
Exercise/Conversion
Restricted Stock Units
2025-03-31−14,184→ 28,369 total
→ Common Stock (14,184 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-31−4,861→ 0 total
→ Common Stock (4,861 underlying)
Exercise/Conversion
Common Stock
2025-03-31+14,184→ 33,546.46 total
Tax Payment
Common Stock
2025-03-31$14.51/sh−3,554$51,569→ 36,884.46 total
Tax Payment
Common Stock
2025-03-31$14.51/sh−1,346$19,530→ 43,169.46 total
Exercise/Conversion
Restricted Stock Units
2025-03-31−4,294→ 0 total
→ Common Stock (4,294 underlying)
Exercise/Conversion
Common Stock
2025-03-31+11,338→ 40,438.46 total
Exercise/Conversion
Common Stock
2025-03-31+4,861→ 41,745.46 total
Tax Payment
Common Stock
2025-03-31$14.51/sh−1,524$22,113→ 40,221.46 total
Award
Stock Option (right to buy)
2025-03-31+99,009→ 99,009 total
Exercise: $14.89→ Common Stock (99,009 underlying)
Award
Restricted Stock Units
2025-03-31+20,147→ 20,147 total
→ Common Stock (20,147 underlying)

Footnotes (8)

[F1]This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
[F2]The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.
[F3]Each RSU converts into one share of Organon common stock.
[F4]The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.
[F5]On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.
[F6]On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026.
[F7]On November 7, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.
[F8]On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.

Documents

1 file

Organon & Co.

CIK 0001821825

Entity typeother